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ABSTRACT Northern blot analysis of the Epstein-Barr
virus DNA polymerase mRNA identified two discrete sizes of
virally encoded polymerase transcripts, 5.08 kb detected in
strains P3HR1, Raji, W-91, and FF-41 and 3.7 kb detected
solely in the prototype B95-8 strain. 3' Sl-nuclease mapping
and analysis ofcDNA sequence generated by RNA-based PCR
demonstrated that the 3.7-kb polymerase mRNA from B95-8
terminates 484 base pairs downstream of the open reading
frame in a region of the genome remarkable for its lack of an
apparent polyadenylylation signal. Moreover, between the
cleavage point and the poly(A) tract of the cDNAs are a series
of inserted nucleotides, mostly adenosine and uridine residues
of unknown origin. A similar analysis of the 3' terminus of the
5.0-kb mRNA from the other cell lines revealed that polyade-
nylylation occurs 1.4 kb downstream of the 1195-8 terminus.
This region is deleted in B95-8, which accounts for the alternate
upstream terminus used in B95-8. Like the 3.7-kb terminus,
the 5.0-kb terminus lacks a canonical polyadenylylation signal,
but contains a rarely used UAUAAA sequence 32 bp upstream
of the poly(A) tail. These results indicate that the mRNA
encoded by the Epstein-Barr virus DNA polymerase gene is
polyadenylylated at two different termini without the use of
canonical signals, raising the possibility of involvement of a
virus-encoded factor in 3' processing of this message.
Epstein-Barr virus (EBV) infections as with herpes-group
virus infections generally are characterized by latency, the
usual state of infection, and by sporadically reactivated
productive infection. These different infection states are
dependent on two different modes of viral DNA replication,
one accomplished by cellular and the other by viral DNA
polymerase (pol). In latent infection, the episomal form ofthe
genome is replicated by host-cell DNA pol, resulting in
orderly duplication of limited copy numbers of episomes
without viral replication and without cellular destruction. In
contrast, in productive EBV infection, large numbers of
linear genomes are replicated and encapsidated, mediated by
expression ofimmediate-early genes involved in activation of
early genes, which include the virus-encoded DNA pol and
its cofactors and other enzymes involved inDNA replication,
as well as late genes that encode structural components ofthe
virion and assembly elements (1).
In the latent state, episomal gene expression is limited to
10 of -100 genes. This latency gene subset also includes
genes involved in cellular immortalization. In latent infec-
tion, expression of all the genes of the virus-productive cycle
is suppressed, including the EBV DNA pol (2-4). A central
question in the transition from latent to reactivated infection
is how expression of this key early gene is either suppressed
or activated so that latent infection is either maintained or
disrupted. A variety of nonspecific stimuli may induce reac-
tivation of latent EBV infection; all seem to have in common
activation of an immediate-early viral transactivator,
BZLF-1, which triggers activation of at least one other
immediate-early gene (BRLF-1), a pre-early gene (BMLF-1),
and the EBV DNA pol among the early genes (5-8). Thus
there are two general possibilities: either the viral pol is
activated secondarily as part of this transcriptional cascade,
or the expression of this gene may have, in addition, its own
controls. The data presented suggest that expression and
processing of the EBV DNA pol mRNA are complex and
bi-level and invoke an unconventional mechanism.
We have recently shown that pol mRNA is not expressed
in latently infected cells, but that a 3.7-kb mRNA encoded by
this gene is expressed in virus-producing cells infected with
the B95-8 strain of EBV (8). The promoter for this gene,
which is TATA-less, is inactive unless transactivated by one
or more of the viral immediate-early genes involved in the
reactivation cascade, which appears to act directly on the
promoter regulatory region, perhaps via two cis-acting ele-
ments required for transcriptional activity.
The 3' end of this message had not been characterized and
was expected to be spliced due to the lack of a canonical
polyadenylylation signal in the vicinity of the termination
codon. However, mapping the 3' terminus by Si-nuclease
analysis and sequencing of pol cDNAsl indicate that the
B95-8 pol transcript is not spliced; instead, an unconventional
mechanism for cleavage/polyadenylylation of the B95-8 pol
mRNA, which does not utilize a canonical polyadenylylation
signal, causes introduction of extraneous adenosine/uridine-
rich nucleotide sequences between the cleavage and polyad-
enylylation sites. In other EBV strains, a larger pol mRNA of
5.08 kb is detected. The 3' end of this message is poly-
adenylylated in a region of the EBV genome deleted in the
B95-8 strain and apparently utilizes a noncanonical polyad-
enylylation signal thought previously to function only in
hepatitis B virus (HBV) (9, 10). These features of the 3'
processing of the EBV pol RNA suggest another level of
regulation of the expression of this gene.
MATERIALS AND METHODS
CeU Lines. B95-8 (11), FF-41 (12), and W-91 (27) are
EBV-producing marmoset B-cell lines grown in RPMI me-
dium supplemented with 8% (vol/vol) fetal calf serum.
P3HR1 (13) and Raji (14) are EBV-positive cell lines derived
from Burkitt's lymphomas and grown in RPMI medium
supplemented with 10% fetal calf serum. Jurkat is an EBV-
negative T-cell line maintained in RPMI medium supple-
mented with 10% fetal calf serum. All cells were maintained
at 370C in a 5% C02/95% air environment.
Abbreviations: EBV, Epstein-Barr virus; HLP, hairy leukoplakia of
the tongue; pol, polymerase; HBV, hepatitis B virus; RACE, rapid
amplification ofcDNAends; ORF, open readingframe; PMA, phorbol
12-myristate 13-acetate.
§To whom reprint requests should be addressed.
$The sequences reported in this paper have been deposited in the
GenBank data base (accession nos. L06826-L06837).
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Induction of Virus Replication. The EBV lytic cycle was
induced by incubating B95-8 cells with phorbol 12-myristate
13-acetate (PMA) and sodium butyrate for 48 h at 30 ng/ml
and 5 mM (final concentrations), respectively. Virus produc-
tion was monitored by indirect immunofluorescence for
early/viral capsid antigens by using high-titer nasopharyn-
geal carcinoma patients' sera and fluorescein isothiocyanate-
conjugated goat anti-human antibody.
RNA Isolation and Northern Blot Analysis. Total cellular
RNA from B95-8, P3HR1, Raji, and FF-41 cells was prepared
48 h postinduction (15), and polyadenylylated RNA was
selected (16) as was RNA from an EBV-positive tissue
specimen of hairy leukoplakia of the tongue (HLP), a per-
missive infection (gift of Nancy Raab-Traub; ref. 26). Sub-
sequently, Northern blot analysis was performed as de-
scribed (8).
Sl-Nuclease and Primer-Extension Analyses. For S1-
nuclease protection assays of viral RNA, mRNA was pre-
pared as described from PMA-induced and uninduced cells.
S1 probes were prepared by subcloning an EBV fragment
(coordinates 153,083-157,119) into phagemid pBS+ (Strata-
gene) and generating single-stranded DNA template by using
helper phage M13K07. An 18-base primer (coordinates
153,083-153,101) was annealed to the template and extended
with Klenow enzyme and [32P]dCTP. After digestion with
Dra I, the strands were separated on a denaturing polyacryl-
amide/urea gel, and the appropriate size band was recovered.
Five micrograms of poly(A)+ RNA was hybridized for 12 h
with 5 x 104 cpm of labeled probe (see Fig. 2) in 30 ttl of 40
mM Pipes (pH 6.4), 1 mM EDTA (pH 8.0), 0.4 M NaCI, and
80% formamide at 45°C. S1 digestion was carried out by
addition of 800 units of S1 nuclease in 300 ,ul of 0.28 M NaCI,
0.05 M sodium acetate (pH 4.5), 4.5 mM ZnSO4, and single-
stranded calf thymus DNA (20 ,ug/ml). Reactions were
terminated by addition of 80 ,ul of a mixture containing 4 mM
ammonium acetate and 50 mM EDTA (pH 8.0). Products
were resolved on 7 M urea/6% polyacrylamide gels and
visualized by autoradiography.
3' Rapid Amplification of cDNA Ends (RACE), Southern
Blot Hybridization, and cDNA Sequence Analysis. 3' RACE
was performed as described by Frohman et al. (17) by using
a gene-specific amplimer within the EBV pol open reading
frame (ORF) (coordinates 153,904-153,924) and an oligo(dT)
primer (GGACTCGAGTCGACATCGAT17) containing re-
striction sites for Sal I, Xho I, and Cla I at the 5' end. PCR
products were resolved on a 1% agarose gel, blotted onto
nitrocellulose filters, fixed by heat, and prehybridized for 1 h
at 37°C in prehybridization solution containing 6x standard
saline citrate (SSC), Sx Denhardt's solution, 0.15% sodium
pyrophosphate, salmon sperm DNA (100 ,g/ml), and 0.1%
SDS. Hybridization was performed in the same solution at
37°C with a 32P-end-labeled pol-specific oligonucleotide
probe (coordinates 153,794-153,830). Filters were washed at
500C in O.lx SSC/0.1% SDS. Positive PCR bands were
cloned into pBS+ (Stratagene), sequenced, and compared
with the published B95-8 sequence.
Construction of AgtlO cDNA Library. A AgtlO library was
prepared from poly(A)+ RNA isolated from B95-8 cells
treated for 48 h with PMA and sodium butyrate by a modi-
fication of the method of Gubler and Hoffman (18). EcoRI
adapters (Promega) were ligated to double-stranded size-
selected (>0.5 kb) cDNA, ligated to EcoRI-digested AgtlO
DNA, and packaged with Gigapack extracts (Stratagene).
Bacteriophage were plated on the C600 hfl- strain of Esch-
erichia coli, and 3' coterminal pol cDNAs were recovered by
hybridization with the 32P-end-labeled oligonucleotide probe
described earlier.
EBV Genomnic Sequence Analysis of Oral HLP DNA. Where
cDNA sequence ofHLP did not correspond to the published
B95-8 sequence, PCR amplification of genomic DNA fol-
lowed by DNA sequencing was used to confirm strain
polymorphisms.
RESULTS
EBV DNA pol Transcription in Different Cell Lines. The
prototype B95-8 strain of EBV contains a 12-kb deletion in
the region of the pol gene studied previously (19). Therefore
it was important to characterize pol mRNA transcription in
other virus-infected cell lines. To analyze the expression of
EBV pol mRNA, PMA and sodium butyrate were used to
induce viral replication. A strand-specific 32P-labeled RNA
probe antisense to the pol ORF (19) was prepared from a
genomic fragment encompassing the coding region of the pol
gene corresponding to positions 153,176 to 156,695 subcloned
into pGem3Z (Promega) (Fig. 1A). Analysis of RNA from
B95-8 cells revealed a predominant transcript of 3.7 kb (Fig.
1B, lane 2) (7). In contrast, in two additional marmoset lines,
FF-41 (lane 8) and W-91 (data not shown), as well as Raji (lane
6) and P3HR1 (lane 4), a major transcript of 5.03 kb was
detected. A minor transcript ofapproximately this size is also
found in B95-8 and is discussed later. Fine mapping of the 5'
end of the pol transcript has disclosed that the pol mRNA
initiation region is identical in each of these cell lines as well
as in B95-8 (8). These results indicated therefore that the
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FIG. 1. Schematic diagram of EBV DNA pol gene and Northern
blot analysis ofpol mRNA from different EBV-positive cell lines. (A)
B95-8 genome: location ofpol ORF (BALF5) in BamHI fragment I/A
is flanked by Sph I sites at 153,176 and 157,118. Fragment Sph I
(153,176) to Stu I (156,695) was subcloned into pGEM3Z and
linearized with HindIII to generate run-off antisense pol transcripts
using T7 RNA polymerase. (B) The probe diagrammed in A was
hybridized to 5 ,ug ofpoly(A)+ RNA from uninduced B95-8 cells (lane
1), induced B95-8 cells (lane 2), uninduced P3HR1 cells (lane 3),
induced P3HR1 cells (lane 4), uninduced Raji cells (lane 5), induced
Raji cells (lane 6), uninduced FF-41 cells (lane 7), and induced FF-41
cells (lane 8). Arrowheads indicate 28S and 18S rRNA positions.
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FIG. 2. Si-nuclease analysis of the 3' end of B95-8 EBV DNA pol
mRNA. (A) 32P-labeled S1 probe (coordinates 153,083-153,645) was
annealed to 5 pzg of poly(A)+ RNA isolated from B95-8 and Jurkat
cells. (B) Lane 1, induced B95-8 cells; lane 2, uninduced B95-8 cells;
lane 3, Jurkat cells; lane M, molecular size markers.
disparity in size of pol mRNA from B95-8 cells and the other
EBV-infected cell lines should be due to differential splicing
or to two different termination sites of the transcripts.
3' Si-Nuclease Mapping ofthe polmRNA Terminus from the
B95-8 Cell Line, To map the 3' end of the pol transcript from
the induced B95-8 cells, an Si-nuclease protection assay was
performed. A uniformly 32P-labeled single-stranded DNA
probe (coordinates 153,083-153,645) antisense to a region
downstream of the stop codon (153,701) of the pol ORF was
synthesized and annealed to polyadenylylated RNA (Fig.
2A). A 433-base protected area of the probe was detected
with the B95-8 RNA (Fig. 2B, lane 1) corresponding to a
termination point of an unspliced mRNA approximately at
EBV coordinate 153,215; protection of probe was not de-
tected with mRNA from uninduced cells (Fig. 2B, lane 2) or
from Jurkat cells, an EBV-negative T-cell line (Fig. 2B, lane
3). Since pol mnRNA is not detected in latently infected cells
(Fig. 1B), it is likely that the large amount of fully protected
probe seen in lanes 1 and 2 represents hybridization to
contaminating viral DNA. Other S1 analyses performed with
longer probes extending into the ORF upstream of the stop
codon all revealed the same extent of protection with B95-8
RNA. Thus 3' S1 mapping of pol mRNA suggested that the
3.7-kb transcript found in B95-8 cells terminates -480 bp
downstream of the ORF (153,210 + 50 nucleotides), in good
agreement with a message initiating at coordinate 156,876 (8).
Sequence Analysis of pol 3' cDNAs from B95-8: Insertion of
Nongenomic Nucleotides Before the Poly(A) Addition. For fine
mapping ofthe 3' terminus ofthe B95-8 pol transcript, mRNA
was used in a PCR reaction to generate cDNAs containing
specifically the 3' end of the pol gene. An oligo(dT) primer
containing a 17-base sequence with three restriction sites (Sal
I, Cla I, and Xho I) at its 5' end was used for first-strand
cDNA synthesis followed by the RACE method (17). The
amplimers used were a 17-base oligonucleotide containing
the three restriction sites and a primer in the pol ORF
immediately upstream of the stop codon (Fig. 3A). This
method would specifically amplify the 3' end of the pol
FIG. 3. 3' RACE analysis of B95-8 DNA pol mRNA. (A) Strategy
for RACE with oligo(dT) primer adapter used for first-strand cDNA
synthesis (open arrow), primer for PCR amplification (closed arrow),
and probe for Southern blot hybridization as shown. (B) Southern
blot analysis of RACE products. Lane 1, untreated; lane 2, treated
with mung bean nuclease.
mRNA. Southern blot hybridization with a 32P-end-labeled
pol-specific internal oligonucleotide (Fig. 3A) identified PCR
products of 710 bp and 600 bp from induced B95-8 cells (Fig.
3B, lane 1). To distinguish if either of these represented
artifactual single-stranded DNA occasionally seen with
RACE procedures (17), mung bean nuclease digestion was
performed (lane 2), which resulted in the elimination of the
smaller band. Therefore cDNAs ofthe 710-bpRACE product
were subcloned into pBS+ (Stratagene) and sequenced. Ad-
ditionally, cDNAs from a AgtlO library generated from PMA-
induced B95-8 cells were subcloned and sequenced. The
results from these two approaches are presented in Fig. 4;
both methods yielded cDNAs with an identical cleavage point
exactly 480 bp downstream of the ORF at nucleotide position
153,215 (T). The region of the genome immediately upstream
of this point is remarkable for its lack of a canonical poly-
adenylylation signal or known variants.
A striking finding in the cDNA sequence of the B95-8 pol
mRNA at the junction of the poly(A) tails was a variable
number (0-24) of nucleotides, predominantly adenosine and
thymidine, inserted downstream of the cleavage site. These
sequences are not genomic in that they do not appear
colinearly (or elsewhere) in the EBV genome. Transfection
genomic







AAA TTA TA( n)
AAA AAT TTA ATT ATG TA(n)
AAA AAAAM AGT A( n)
AAAmm AMA ATA( n)




AAA AAT ATT TTA(n)
AAA AMA ATA TA(n)
AMAM Am A(n)
FIG. 4. Summary of sequence of B95-8 pol 3' cDNA tails
disclosed by RACE and AgtlO cDNA library. All cDNAs were
colinear with the EBV genome up to B95-8 coordinate 153,215.
m
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with pEBV-R/Z, a plasmid construct that expresses the EBV
immediate-early transactivators, BRLF-1 and BZLF-1,
yielded the same termination point (data not shown), which
indicates that this termination point is not a result of PMA
induction. Another viral cDNA (EBV thymidine kinase)
generated by these methods contains perfect polyadenylyl-
ated tails, no inserted sequence, and a consensus AAUAAA
polyadenylylation signal (C. Liu and F.B.F., unpublished
results).
Sequence Analysis of pol 3' cDNAs from Raji and P3HR1
Cell Lines and Wild-Type Virus-Infected Tissue from Oral
HLP. By using the same amplimers shown in Fig. 2A, 3'
RACE was used to identify the pol RNA terminus from Raji
and P3HR1 cells and from unpassaged wild-type virus-
infected tissue from HLP. As shown in Fig. 5, Southern blot
analysis revealed multiple PCR products detected in PMA-
induced virus-infected cell lines (lanes 1 and 2) as well as from
HLP (lane 3). However, digestion with mung bean nuclease
disclosed that only the 2.1-kb band was double-stranded
DNA (data not shown). Subcloning into pBS+ followed by
sequence analysis of the three 2.1-kb PCR products revealed
that the terminus used in these strains is located 1.4 kb
downstream of the B95-8 terminus, a region of the EBV
genome that is deleted in B95-8 (Fig. 6A) (20). Additional 3'
sequencing of the other strains past the B95-8 terminus
demonstrated colinearity of the cDNAs for these strains with
the genome and disclosed transcription through an adjacent
ORF, BILF1 (Fig. 6A). At this second terminus, there are no
inserted nucleotides. Furthermore the 3' end ofthese cDNAs
also lacks a canonical polyadenylylation signal, but has a
UAUAAA sequence 32 bp upstream of the terminus, which
is the sequence thought to function as a noncanonical poly-
adenylylation signal in the HBV genome for HBV S antigen
(9, 10).
Three additional nucleotides were identified in the HLP
cDNA at the 3' terminus. These nucleotides, according to the
sequence data of Parker et al. (20), are not contained within
the Raji genome. To determine ifthese additional nucleotides
were part of the HLP wild-type genome, the genomic HLP
DNA encompassing the 5.08-kb mRNA terminus was PCR-
amplified and sequenced. This analysis disclosed that the
three additional nucleotides were present in the HLP genome
colinear with the pol 5.08-kb mRNA and thus did not repre-
sent extraneous insertions (data not shown).
Thus pol mRNA can terminate at either of two points, one
of which is preferred (5.08-kb mRNA), and an alternate
upstream site, used solely in B95-8 (3.7-kb mRNA). Although
the cleavage point at both sites is precise, the polyadenyly-
lation process at the alternate site seems to be less precise
with up to 20 nucleotides inserted before the poly(A) tract.
Neither terminus contains a conventional polyadenylylation
signal or recognized variants, but the major pol mRNA
termination region may contain a unique poly(A) signal.
Genomic Sequence of B95-8 3' pol Untrlated Region
Compared with P3HR1, Raji, and Wild-Type Viral pol RNA
Sequence from HLP. As shown in Fig. 6A, the downstream




FIG. 5. 3' RACE analysis of
850- * Raji, P3HR1, and HLP DNA pol
mRNA. One microgram of
poly(A)+ RNA isolated from HLP
iD 7- _ or induced Raji and P3HR1 cells
was treated as in Fig. 2 followed
100°-_''' -rt.23;)t'' by Southern blot hybridization.
Lane 1, Raji; lane 2,P3HRH; lane
3, HLP.
deleted in the B95-8 genome, which necessitates use of an
alternative termination site for the B95-8 strain. However,
these observations do not explain why this specific upstream
site is selected in B95-8 or why this site, if present in the
5.08-kb mRNA, is ignored in the other strains. To determine
whether the B95-8 termination point is missing in P3HR1 and
Raji and also to localize a potential cryptic polyadenylylation
signal contained only in B95-8, cDNAs of the region of
overlap were sequenced from these two strains and compared
with the published B95-8 sequence (Fig. 6B). Approximately
155 bp upstream of the B95-8 pol 3' terminus, there appear
three base substitutions in the P3HR1 cDNA as well as a
two-base deletion. In the Raji cDNA sequence in this region,
there was a single-base substitution. However, analysis ofthe
region surroundiuig the position where B95-8 mRNA termi-
nates did not reveal any sequence changes in the P3HR1 and
Raji cDNAs. Thus the B95-8 terminus sequence is essentially
preserved but not used in the other strains. The results also
indicate that strain polymorphism has not created a cryptic
polyadenylylation signal in the B95-8 genome, but perhaps
hints at a distal sequence (155 bp upstream) needed for
processing of this mRNA.
DISCUSSION
Northern blot analysis of B95-8 pol mRNA compared with
other laboratory strains indicates there are two discrete sizes
A
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AGA~GGAGAT GOIXOAGGAC CCGGCCTACG CA CGGCGGCGTTCC GTGGCCTGG
ATCATTATTT CGACAAGCTG CTCCAAGGAG CGGCCAT CCTCCAGTGC CTCTTTGATA
ACAACTCCGG GGCCGCCCTCTCCGTCCTCC AGAATTTTAC AGCCCGGICC CCATTC13
ACCCAAAGTG AGGGGGCCTG AGACTGGACC CTACTACTAT TCTCTGTTT
AGAGAGCGGC GAGAGCAGAC TCCGAATATC CCCAAAGTCA GA A GCT
TAGCATGAGGCGCGAGAG CGAGCGGGAT GGGGCTGG0G AAGATTCCCA
ACCGGGGGAT CGCTGAATCT AGTATGAAGG CTGGCAAAGA TMCMCAGTGGAQGOGA
C
GTGCAGGGGG CTCGGCATTC CTAGGG GAGCCTCnCC TTGAGGGCAA AGACCCCCCC
T---A (9 A-C
AAGCCTCTCA TCAGAATCTC AACCGAMC GTCAGCCGCT TCAGACAGCC GOGGTTGTCA
TCATCATCGG GAAAGGCGGT GGGATCATGA AGCCCCCAGG GGAGCGTGOC CCGTGGATCT
GTGAAACTCA CAGMAM TCTCCAAATC GCTCCTTGCA ACAATGGACAGGGG
AAtGCAGAAA ATAGTCTGGA AGTCCACCAG GCAGGGAGGT GGC 153174
FIG. 6. Polyadenylylation of 3.7-kb and 5.08-kb EBV pol mRNA
species. (A) Polyadenylylation of the 3.7-kb pol transcript is as
indicated upstream of BILF1. Polyadenylylation of the 5.08-kb pol
transcript is within a 12-kb region deleted in the B95-8 genome. The
putative polyadenylylation signal (TATAAA) is indicated upstream
of the 5.08-kb mRNA cleavage/polyadenylylation site ( T ). The
region of sequence polymorphism is indicated by the filled box. (B)
Genomic sequence of B95-8 DNA demonstrating the cleavage/
polyadenylylation site ( t ) of the 3.7-kb mRNA. Base substitutions
and deletions found in P3HR1 are indicated below the B95-8 se-
quence. The base substitution common to P3HR1 and Raji DNA is
circled.
Biochemistry: Furnari et al.
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of EBV poi transcripts, 5.08 kb seen in strains P3HR1, Raji,
W91, and FF-41, and 3.7 kb detected solely in the B95-8
strain. Sequence analysis of the 3' end of each of these
transcripts revealed that the B95-8 pol mRNA contains a
480-bp untranslated sequence terminating at map coordinate
153,215, whereas the other strains including wild-type viral
Rt4A retrieved directly from HLP terminate 1.4 kb further
downstream in a region ofthe genome that is deleted in B95-8.
All the cDNAs that were sequenced contained terminal
poly(A) stretches with no evidence of splicing. Thus neither
the 3.7-kb nor the 5.08-kb pol transcript is spliced at either the
5' (8) or 3' ends, so that the difference in message size is due
to alternative cleavage/polyadenylylation sites. A transcript
of =5 kb detected in B95-8 (Fig. 1B, lane 2), which appears
to contain some overlapping pol sequence, probably arises in
part from read-through transcription from the adjacent
BALF4 ORF (Fig. 6A). The possibility that this B95-8
transcript contains the same 3' pol mRNA end found in the
other strains can be excluded due to the 12-kb deletion in the
B95-8 genome, which encompasses the 5.03-kb polyadenyl-
ylation site. In addition, pol-specific cDNAs sequenced from
a AgtlO library as well as 3' RACE failed to generate any
clones downstream of the 3.7-kb polyadenylylation site.
An unexpected feature ofthese polyadenylylated messages
is the absence of a canonical polyadenylylation signal or any
of its variants (21). However, the 5.08-kb pol transcript does
contain a UAUAAA motif 17-bp upstream of the point of
termination; this motif is thought to function in the HBV
genome (9, 22) and was shown to be necessary but not
sufficient to obtain polyadenylylation of simian virus 40-
HBV chimeric transcripts (10), indicating the involvement of
flanking sequence. In vitro assays also failed to demonstrate
that this sequence alone is able to mediate cleavage and
polyadenylylation (23), which may suggest that a factor
produced in virus-infected cells is needed to render this
noncanonical signal functional.
An unusual feature ofthe 3.7-kb pol transcript is the variable
number of nongenomic adenosine/uridine nucleotides in-
serted immediately after the cleavage site before the poly(A)
tract. The source of these sequences is unknown, but the
inserted sequence appears to form variants of polyadenylyla-
tion signals across the genomic/nongenomic junction in many
of the cDNAs as shown in Fig. 3. Perhaps this sequence is
contributed by RNA pol II slipping in this region of the
template leading to a repeated synthesis of adenosine and
uridine. RNA pol II slippage has been described as a mech-
anism generating stretches of adenosine residues at the 3' end
of transcripts encoded by vesicular stomatitis virus (24) and
influenza virus (25). Generation of a polyadenylylation signal
in this manner for the EBV pol gene may then lead to
processing of the pol mRNA by the cellular machinery.
At both termini, cleavage is precise. However at the
terminus of the 5.08-kb message, there are no inserted
nucleotides. The downstream site that is deleted in B95-8 and
used in the longer message is clearly the preferred terminus
for pol mRNA, since it is used in all other strains tested so far.
The single random analysis of RNA from wild-type unpas-
saged virus-infected tissue also indicates that this is the
authentic pol mRNA terminus. However, what determines
selection of the upstream terminus used in B95-8 and why this
site, which was determined to be present in all other viral
strains by Sl-nuclease mapping (data not shown) and cDNA
sequence analysis, is ignored in the other viral strains are
unknown.
The lack of canonical polyadenylylation signals at both pol
mRNA termini is very unusual if not unprecedented (21). The
question arises how this deficit is overcome. One possibility
is that a virally induced or encoded prereplicative protein is
needed to accomplish polyadenylylation. Such a protein
might act in trans posttranscriptionally to fix the cleavage
points for the termini and might participate in the cellular
polyadenylylation mechanism. Thus induction with PMA or
EBV immediate-early transactivation may supply a factor
needed for polyadenylylation, and such a protein could then
be involved in timing and rapid amplification of functional
mRNA needed for viral replication. Consequently, regulation
of expression of the EBV pol gene would require both
activation of the promoter for the gene and also induction, via
the EBV transcriptional cascade, of a factor that interacts in
some way with the 3' mRNA processing machinery to
generate stable pol mRNA.
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